Is TVTX up or down today?
TVTX is down 6.77% today, last at 48.87. This stock moved -6.77% versus the prior close.
TVTX · TVTX
TVTX (TVTX) is trading at 48.87, down 6.77% on the session. TVTX sits at the 57% mark of its 52-week range, carries a 14-day RSI of 37, and trades below its 50-day average. Over the past month it is down 12.70%.
Leading the coverage: “Why Travere Therapeutics Stock Is Up 6.1% And What's Next - Simply Wall St” (Google News, 21h ago).
TVTX trades on a trailing P/E of 29.6 and is running 6.78% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
TVTX is down 6.77% today, last at 48.87. This stock moved -6.77% versus the prior close.
Leading the coverage: “Why Travere Therapeutics Stock Is Up 6.1% And What's Next - Simply Wall St” (Google News, 21h ago). Dominant story: Why Travere Therapeutics Stock Is Up 6.1% And What's Next - Simply Wall St (3 sources, neutral) RSI is 37 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
Why Travere Therapeutics Stock Is Up 6.1% And What's Next - Simply Wall St
Analysts Have Conflicting Sentiments on These Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Inspire Medical Systems (INSP) and Travere Therapeutics (TVTX) - The Globe and Mail
Canaccord Genuity Maintains Buy on Travere Therapeutics, Raises Price Target to $72
TVTX Maintained by Guggenheim -- Price Target Lowered to $78 - GuruFocus
Guggenheim Maintains Buy on Travere Therapeutics, Lowers Price Target to $78